Some neuroinflammatory diseases result in significant abnormal amounts of metabolic peptides like GLP-1, GIP, and PP, which are crucial hormonal peptides needed to regulate insulin secretion, blood glucose level regulation, and gastric emptying; these processes are significantly dysregulated in patients with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.